Tuesday, November 11, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Oracle’s AI Hype Faces Reality Check as Shares Tumble

Felix Baarz by Felix Baarz
September 26, 2025
in AI & Quantum Computing, Analysis, Tech & Software
0
Oracle Stock
0
SHARES
186
VIEWS
Share on FacebookShare on Twitter

A recent “Sell” recommendation from investment bank Rothschild & Redburn has triggered a sharp sell-off in Oracle shares, casting doubt on the software giant’s standing as a primary beneficiary of the artificial intelligence boom. The stock fell approximately 5% following the report, which argued that the revenue potential from Oracle’s cloud business has been “significantly overestimated.” This decline extends a downward trend that has pulled the share price around 16% below its recent peak.

Spectacular Bookings Mask Underlying Concerns

The bearish assessment presents a stark contrast to the investor enthusiasm that surrounded Oracle just weeks ago. In early September, the company reported first-quarter results for its 2026 fiscal year that featured a staggering 359% surge in remaining performance obligations, which climbed to $455 billion. This massive backlog was largely attributed to multi-billion dollar AI contracts with industry leaders, including OpenAI.

However, a closer look at the actual financial results reveals a disconnect between these future promises and current profitability. Key figures from the report include:
* Total Revenue: Increased by 12% to $14.9 billion.
* Cloud Revenue: Grew 28% to $7.2 billion.
* Cloud Infrastructure (Core AI Business): Jumped 55%.
* Earnings Per Share: Decreased by 2% to $1.01.

Should investors sell immediately? Or is it worth buying Oracle?

Strategic Moves and Fundamental Doubts

Amid the stock’s weakness, news emerged of a potential strategic coup: Oracle, alongside partners, is reportedly poised to acquire a 50% stake in TikTok’s US operations. This move would place the company at the center of the restructuring of one of the world’s most popular social media platforms.

Nevertheless, market experts question whether this deal is enough to alleviate fundamental concerns about Oracle’s business model. The central issue for investors remains timing: when will the billions of dollars in AI-related bookings finally translate into substantial bottom-line growth? While the cloud infrastructure division is expanding rapidly, its performance has not yet been sufficient to offset softer results in other segments of the business. The initial AI euphoria is now being tested by the market’s demand for tangible financial returns.

Ad

Oracle Stock: Buy or Sell?! New Oracle Analysis from November 11 delivers the answer:

The latest Oracle figures speak for themselves: Urgent action needed for Oracle investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 11.

Oracle: Buy or sell? Read more here...

Tags: Oracle
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Aclaris Therapeutics Stock
Analysis

Aclaris Therapeutics Shares Tumble Following Quarterly Report

November 11, 2025
Bioatla Inc Stock
Analysis

BioAtla Shares Surge on Promising Cancer Therapy Data

November 11, 2025
Globus Medical Stock
Analysis

Globus Medical Shares Surge on Exceptional Quarterly Performance

November 11, 2025
Next Post
D-Wave Quantum Stock

Quantum Computing Rivalry Intensifies as D-Wave Shares Retreat from Peak

Rocket Lab USA Stock

Leadership Share Sales Cast Shadow Over Rocket Lab's Operational Success

Synopsys Stock

Synopsys Shares Plummet Following Disappointing Earnings Report

Recommended

MGM Resorts Stock

Leadership Transition Amid Strategic Momentum at MGM Resorts

2 months ago
Technology Quantum computing Stock Exchange

Microchip Technology Achieves ISOSAE 21434 Road Vehicle Cybersecurity Engineering Standard Certification

2 years ago
Investings on laptop and finances

Goldman Sachs Analyst Upgrades Church Dwight Co to Buy with Increased Price Target

2 years ago
Hensoldt Stock

Defense Stock Under Pressure as Analyst Issues Sell Rating

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Globus Medical Shares Surge on Exceptional Quarterly Performance

FAT Brands Stock: Navigating a Critical Juncture

TransMedics Stock: Strong Fundamentals Clash With Technical Weakness

Capital Southwest’s Billion-Dollar Question: Growth Catalyst or Shareholder Dilution?

Euronet Worldwide Shares: Navigating Troubled Waters

Hercules Capital: Can the High-Yield Dividend Withstand Mounting Pressure?

Trending

Aclaris Therapeutics Stock
Analysis

Aclaris Therapeutics Shares Tumble Following Quarterly Report

by Dieter Jaworski
November 11, 2025
0

Aclaris Therapeutics witnessed a significant selloff in its stock price after releasing disappointing third-quarter 2025 financial results....

Bioatla Inc Stock

BioAtla Shares Surge on Promising Cancer Therapy Data

November 11, 2025
Protara Therapeutics Stock

Protara Therapeutics Stock: Clinical Progress Fuels Investor Optimism

November 11, 2025
Globus Medical Stock

Globus Medical Shares Surge on Exceptional Quarterly Performance

November 11, 2025
FAT Brands Stock

FAT Brands Stock: Navigating a Critical Juncture

November 11, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Aclaris Therapeutics Shares Tumble Following Quarterly Report
  • BioAtla Shares Surge on Promising Cancer Therapy Data
  • Protara Therapeutics Stock: Clinical Progress Fuels Investor Optimism

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com